Dietary fish protein hydrolysates containing bioactive motifs affect serum and adipose tissue fatty acid compositions, serum lipids, postprandial glucose regulation and growth in obese Zucker fa/fa rats

British Journal of Nutrition

Volumn 116, Issue 8, 2016, Pages 1336-1345

  Drotningsvik, Aslaug ^a   Mjos, Svein A ^a,b   Pampanin, Daniela M ^c   Slizyte, Rasa ^d   Carvajal, Ana ^d   Remman, Tore ^e   Hogoy, Ingmar ^f   Gudbrandsen, Oddrun A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b NOFIMA   (Norway)

^c INTERNATIONAL RESEARCH INSTITUTE OF STAVANGER   (Norway)

^d SINTEF OCEAN   (Norway)

^e Nutrimar As   (Norway)

^f Blue Protein   (Norway)

Author keywords

Bioactive motifs; Cholesterol; Herring; Obesity; Salmon

Indexed keywords

ARGININE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE; METHIONINE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PROTEIN HYDROLYSATE; SATURATED FATTY ACID; TAURINE; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; BIOLOGICAL MARKER; FISH PROTEIN; INDUSTRIAL WASTE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FOOD COMPOSITION; FOOD INTAKE; GLYCEMIC CONTROL; GROWTH REGULATION; HERRING; LIPID COMPOSITION; LIPID METABOLISM; MALE; NONHUMAN; POSTPRANDIAL STATE; PROTEIN MOTIF; RAT; SALMONINE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHEY; ZUCKER FATTY RAT; ADVERSE EFFECTS; ANALYSIS; ANIMAL; AQUACULTURE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; ECONOMICS; FISH PRODUCT; FISHERY; FOOD INDUSTRY; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INDUSTRIAL WASTE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; WHITE ADIPOSE TISSUE; ZUCKER RAT;

ADIPOSE TISSUE, WHITE; ADIPOSITY; AMINO ACID MOTIFS; ANIMALS; ANTI-OBESITY AGENTS; AQUACULTURE; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH PRODUCTS; FISH PROTEINS; FISHERIES; FOOD-PROCESSING INDUSTRY; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INDUSTRIAL WASTE; MALE; OBESITY; PROTEIN HYDROLYSATES; RATS, ZUCKER; SALMON; WEIGHT GAIN;

EID: 84991711484     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516003548     Document Type: Article

References (72)

1. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30, 785-807.
2. Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, 1645S-1654S.
3. Smith KM, Barraj LM, Kantor M, et al. (2009) Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999-2002). Public Health Nutr 12, 1261-1269.
4. Kromhout D & de Goede J (2014) Update on cardiometabolic health effects of omega-3 fatty acids. Curr Opin Lipidol 25, 85-90.
5. Glauber H, Wallace P, Griver K, et al. (1988) Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108, 663-668.
6. Popp-Snijders C, Schouten JA, Heine RJ, et al. (1987) Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 4, 141-147.
7. Eslick GD, Howe PR, Smith C, et al. (2009) Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol 136, 4-16.
8. Nettleton JA & Katz R (2005) n-3 Long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105, 428-440.
9. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30.
10. Jacques H (1990) Effects of dietary fish protein on plasma cholesterol and lipoproteins in animal models and in humans. Monogr Atheroscler 16, 59-70.
11. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31, 1560-1566.
12. Vikoren LA, Nygard OK, Lied E, et al. (2013) A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. Br J Nutr 109, 648-657.
13. Ouellet V, Marois J, Weisnagel SJ, et al. (2007) Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: a randomized controlled trial. Diabetes Care 30, 2816-2821.
14. Wergedahl H, Liaset B, Gudbrandsen OA, et al. (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers Acyl-CoA: cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134, 1320-1327.
15. Hosomi R, Fukunaga K, Arai H, et al. (2011) Fish protein decreases serum cholesterol in rats by inhibition of cholesterol and bile acid absorption. J Food Sci 76, H116-H121.
16. Lavigne C, Marette A & Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278, E491-E500.
17. Pilon G, Ruzzin J, Rioux LE, et al. (2011) Differential effects of various fish proteins in altering body weight, adiposity, inflammatory status, and insulin sensitivity in high-fat-fed rats. Metabolism 60, 1122-1130.
18. Madani Z, Louchami K, Sener A, et al. (2012) Dietary sardine protein lowers insulin resistance, leptin and TNF-alpha and beneficially affects adipose tissue oxidative stress in rats with fructose-induced metabolic syndrome. Int J Mol Med 29, 311-318.
19. Lavigne C, Tremblay F, Asselin G, et al. (2001) Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol Endocrinol Metab 281, E62-E71.
20. Shukla A, Bettzieche A, Hirche F, et al. (2006) Dietary fish protein alters blood lipid concentrations and hepatic genes involved in cholesterol homeostasis in the rat model. Br J Nutr 96, 674-682.
21. Drotningsvik A, Mjos SA, Hogoy I, et al. (2015) A low dietary intake of cod protein is sufficient to increase growth, improve serum and tissue fatty acid compositions, and lower serum postprandial glucose and fasting non-esterified fatty acid concentrations in obese Zucker fa/fa rats. Eur J Nutr 54, 1151-1160.
22. Hagen IV, Helland A, Bratlie M, et al. (2016) High intake of fatty fish, but not of lean fish, affects serum concentrations of TAG and HDL-cholesterol in healthy, normal-weight adults: a randomised trial. Br J Nutr 116, 648-657.
23. FAO Fisheries Department (2014) The State of World Fisheries and Aquaculture. Rome: FAO.
24. Ryan JT, Ross RP, Bolton D, et al. (2011) Bioactive peptides from muscle sources: meat and fish. Nutrients 3, 765-791.
25. Kim SK & Wijesekara I (2010) Development and biological activities of marine-derived bioactive peptides: a review. J Funct Foods 2, 1-9.
26. Pampanin DM, Larssen E, Provan F, et al. (2012) Detection of small bioactive peptides from Atlantic herring (Clupea harengus L.). Peptides 34, 423-426.
27. Pampanin DM, Haarr MB & Sydnes MO (2016) Natural peptides with antioxidant activity from Atlantic cod and Atlantic salmon residual materia. Int J Appl Res Nat Prod 9, 1-8.
28. de Artinano AA & Castro MM (2009) Experimental rat models to study the metabolic syndrome. Br J Nutr 102, 1246-1253.
29. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
30. Oterhals A & Samuelsen TA (2015) Plasticization effect of solubles in fishmeal. Food Res Int 69, 313-321.
31. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
32. Meier S, Mjos SA, Joensen H, et al. (2006) Validation of a onestep extraction/methylation method for determination of fatty acids and cholesterol in marine tissues. J Chromatogr A 1104, 291-298.
33. Sciotto C & Mjos SA (2012) Trans isomers of EPA and DHA in omega-3 products on the European market. Lipids 47, 659-667.
34. Wasta Z & Mjos SA (2013) A database of chromatographic properties and mass spectra of fatty acid methyl esters from omega-3 products. J Chromatogr A 1299, 94-102.
35. Nagaoka S, Futamura Y, Miwa K, et al. (2001) Identification of novel hypocholesterolemic peptides derived from bovine milk beta-lactoglobulin. Biochem Biophys Res Commun 281, 11-17.
36. Li-Chan EC, Hunag SL, Jao CL, et al. (2012) Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. J Agric Food Chem 60, 973-978.
37. Ben Henda Y, Laamari M, Lanneluc I, et al. (2015) Di and tripeptides from marine sources can target adipogenic process and contribute to decrease adipocyte number and functions. J Funct Foods 17, 1-10.
38. Yamauchi R, Ohinata K & Yoshikawa M (2003) Beta-lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor. Peptides 24, 1955-1961.
39. Yoshikawa M, Fujita H, Matoba N, et al. (2000) Bioactive peptides derived from food proteins preventing lifestylerelated diseases. Biofactors 12, 143-146.
40. Lammi C, Zanoni C & Arnoldi A (2015) IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway. J Funct Foods 14, 469-478.
41. Umezawa H, Aoyagi T, Ogawa K, et al. (1984) Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria. J Antibiot (Tokyo) 37, 422-425.
42. Lyapina LA, Myasoedov NF, Grigorjeva ME, et al. (2013) The modern concept of the regulatory role of peptides of the glyproline family in the correction of hemostasis system function during development of diabetes mellitus. Biol Bull 40, 386-393.
43. Myasoedov NF, Lyapina LA, Grigorjeva ME, et al. (2016) Mechanisms for glyproline protection in hypercholesterolemia. Pathophysiology 23, 27-33.
44. Yoshikawa M (2015) Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects. Peptides 72, 208-225.
45. Takenaka Y, Nakamura F, Yamamoto T, et al. (2003) Enterostatin (VPDPR) and its peptide fragment DPR reduce serum cholesterol levels after oral administration in mice. Biosci Biotechnol Biochem 67, 1620-1622.
46. Kagawa K, Matsutaka H, Fukuhama C, et al. (1996) Globin digest, acidic protease hydrolysate, inhibits dietary hypertriglyceridemia and Val-Val-Tyr-Pro, one of its constituents, possesses most superior effect. Life Sci 58, 1745-1755.
47. Matsui T, Oki T & Osajima Y (1999) Isolation and identification of peptidic alpha-glucosidase inhibitors derived from sardine muscle hydrolyzate. Z Naturforsch C 54, 259-263.
48. Yamada Y, Muraki A, Oie M, et al. (2012) Soymorphin-5, a soy-derived mu-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARalpha systems in diabetic KKAy mice. Am J Physiol Endocrinol Metab 302, E433-E440.
49. Suckling KE, Benson GM, Bond B, et al. (1991) Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment. Atherosclerosis 89, 183-190.
50. Farris EJ & Griffith JQ (1949) The Rat in Laboratory Investigation. Philadelphia, PA: J. B. Lippincott Company.
51. Feskens EJ, Bowles CH & Kromhout D (1991) Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14, 935-941.
52. Whelton SP, He J, Whelton PK, et al. (2004) Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 93, 1119-1123.
53. Patel PS, Forouhi NG, Kuijsten A, et al. (2012) The prospective association between total and type of fish intake and type 2 diabetes in 8 European countries: EPIC-InterAct Study. Am J Clin Nutr 95, 1445-1453.
54. Nkondjock A & Receveur O (2003) Fish-seafood consumption, obesity, and risk of type 2 diabetes: an ecological study. Diabetes Metab 29, 635-642.
55. Kromhout D, Bosschieter EB & de Lezenne Coulander C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312, 1205-1209.
56. Byun HG & Kim SK (2002) Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin. J Biochem Mol Biol 35, 239-243.
57. Bhathena SJ, Berlin E, Judd JT, et al. (1991) Effects of omega 3 fatty acids and Vitamin E on hormones involved in carbohydrate and lipid metabolism in men. Am J Clin Nutr 54, 684-688.
58. Mori TA, Bao DQ, Burke V, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70, 817-825.
59. Lara JJ, Economou M, Wallace AM, et al. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 193, 213-221.
60. Kulakowski EC & Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33, 2835-2838.
61. Roden M, Price TB, Perseghin G, et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859-2865.
62. Jao CL, Hung CC, Tung YS, et al. (2015) The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes. Biomedicine (Taipei) 5, 14.
63. Kritchevsky D, Tepper SA, Czarnecki SK, et al. (1982) Atherogenicity of animal and vegetable protein. Influence of the lysine to arginine ratio. Atherosclerosis 41, 429-431.
64. Morita T, Oh-hashi A, Takei K, et al. (1997) Cholesterollowering effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet. J Nutr 127, 470-477.
65. Murakami S, Nara Y & Yamori Y (1996) Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. Life Sci 58, 1643-1651.
66. Bremer J (1955) The conjugation of glycine with cholic acid and benzoic acid in rat liver homogenate. Acta Chem Scand 9, 268-271.
67. Morikawa K, Kondo I, Kanamaru Y, et al. (2007) A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem Biophys Res Commun 352, 697-702.
68. Wergedahl H, Gudbrandsen OA, Rost TH, et al. (2009) Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats. Nutrition 25, 98-104.
69. Gudbrandsen OA, Wergedahl H, Liaset B, et al. (2005) Dietary proteins with high isoflavone content or low methionineglycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94, 321-330.
70. Gudbrandsen OA, Wergedahl H, Liaset B, et al. (2008) Dietary single cell protein reduces fatty liver in obese Zucker rats. Br J Nutr 100, 776-785.
71. Gudbrandsen OA, Wergedahl H, Mork S, et al. (2006) Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. Br J Nutr 96, 249-257.
72. Sugano M, Ishiwaki N, Nagata Y, et al. (1982) Effects of arginine and lysine addition to casein and soya-bean protein on serum lipids, apolipoproteins, insulin and glucagon in rats. Br J Nutr 48, 211-221.